Physician profile
Lawrence Vanmeter
NPI 1639117948
$804.30
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $306 · 2021: $134 · 2022: $19.54 · 2024: $93.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $93.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $93.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $103.78 | 2019-2021 | |
| Novo Nordisk INC | $99.29 | 2019-2024 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $93.86 | 2019-2020 | |
| Amgen INC. | $76.46 | 2019-2020 | |
| Pfizer INC. | $61.79 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.71 | 2020 | |
| Eisai INC. | $36.81 | 2021 | |
| Sanofi Pasteur INC. | $35.62 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $27.61 | 2019 | |
| Phathom Pharmaceuticals, INC. | $26.76 | 2024 | Voquezna |
| Boston Scientific Corporation | $25.53 | 2024 | Watchman Flx |
| Vanda Pharmaceuticals INC. | $25.37 | 2020 | |
| La Jolla Pharmaceutical Company | $24.91 | 2020 | |
| Upsher-Smith Laboratories LLC | $21.90 | 2021 | |
| Inspire Medical Systems, INC. | $20.53 | 2024 | Inspire |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $19.37 | 2020 | |
| Abbvie INC. | $19.26 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $18.19 | 2020 | |
| Lilly USA, LLC | $15.22 | 2019 | |
| Seqirus USA INC | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Vanmeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.